Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet 398(10317):21602172
No matter how GLP-1 nausea manifests, there are ways to manage this side effect
Compounded semaglutide and tirzepatide are both GLP-1 receptor agonistsbut tirzepatide adds a second mechanism by activating GIP receptors
Under Section 503B, outsourcing facilities may not compound drugs that are essentially copies of one or more approved drug products, and they are prohibited from compounding using bulk drug substances unless the substance appears on FDA's 503B bulks list or the drug appears on FDA's drug shortagel at the time of compounding, distribution and dispensing
Besides, an altered metabolic state under extended METH access could also play a role